Publication | Closed Access
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
29
Citations
0
References
2020
Year
In patients with RA who had an inadequate response to MTX, baricitinib was associated with significant clinical improvements as compared with placebo.